Related Experiment Video
Updated: Oct 17, 2025
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
260
Flavonoids and intestinal microbes interact to alleviate depression
Ke Zhao1, Mei Yao1, Xin Zhang1
1Department of Food Science and Engineering, Ningbo University, Ningbo, P.R. China.
Journal of the Science of Food and Agriculture
|October 9, 2021
Summary
Flavonoids benefit health by interacting with gut microbes. These interactions, particularly through the gut-brain axis, show potential for alleviating depression by modulating intestinal microorganisms.
Area of Science:
- Nutritional Biochemistry
- Microbiology
- Neuroscience
Background:
- Flavonoids possess diverse health benefits but often exhibit low bioavailability.
- Intestinal flora metabolize flavonoids into various derivatives, mediating their effects.
- Flavonoids can influence gut microbial composition and structure, impacting human health.
Purpose of the Study:
- To explore the interplay between flavonoids and intestinal microbes in mitigating depression.
- To understand how flavonoid-microbe interactions influence the gut-brain axis in depression.
Main Methods:
- Review of existing literature on flavonoid metabolism by gut microbiota.
- Analysis of studies linking gut microbiota alterations to depression development.
- Examination of research on the gut-brain axis and microbial modulation of mood.
Main Results:
- Flavonoid derivatives produced by gut microbes play a crucial role in their health effects.
- Depression is associated with specific changes in the gut microbiome's type and abundance.
- Gut microbes demonstrate a significant capacity to ameliorate depressive symptoms.
Conclusions:
- The interaction between flavonoids and intestinal microbiota is a promising avenue for depression management.
- Targeting gut microbes with flavonoids may offer a novel therapeutic strategy for mood disorders.
Related Concept Videos
01:25Antidepressant Drugs: Overview
892
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
892
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
238
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
238
01:23Antidepressant Drugs: MAOIs and Other Agents
436
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
436
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
497
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
497
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
752
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
752
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
375
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
375